BVS vs RVTY: fair value comparison
Bioventus Inc. and Revvity, Inc. · Updated 2026-08-31
BVS currently screens as fairly valued while RVTY screens as overvalued. Within Healthcare, BVS currently sits closer to the top of our discount ranking. RVTY carries the stronger quality grade.
| BVS | RVTY | |
|---|---|---|
| Verdict | Fairly valued | Overvalued |
| Last price | $13.47 | $128.80 |
| 12-month range | $6.56–$13.47 | $86.68–$115.22 |
| Sector rank | #86 of 113 Healthcare | #91 of 113 Healthcare |
| Quality grade | D | A |
| Momentum grade | B | B |
| Leverage | Moderate | Low |
| Margin trend | — | Contracting |
| Revenue growth | — | Modest |
| RSI zone | Neutral | Overbought |
| 50/200-day trend | Uptrend | — |
| DCF cross-check | — | Overvalued |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: BVS fair value analysis · RVTY fair value analysis